Azimuth Capital Management’s Core Laboratories CLB Stock Holding History

Azimuth Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,380	Closed	-$842K	–	283
2015 Q2	$842K	Sell	7,380 -215	-3%	-$26.1K	0.08%	207
2015 Q1	$794K	Buy	7,595 +3,665	+93%	+$390K	0.08%	205
2014 Q4	$473K	Sell	3,930 -2,280	-37%	-$299K	0.05%	231
2014 Q3	$909K	Hold	6,210	–	–	0.1%	191
2014 Q2	$1.04M	Sell	6,210 -9,545	-61%	-$1.7M	0.12%	182
2014 Q1	$3.13M	Sell	15,755 -290	-2%	-$54.7K	0.38%	90
2013 Q4	$3.06M	Buy	16,045 +825	+5%	+$154K	0.37%	92
2013 Q3	$2.58M	Buy	15,220 +4,140	+37%	+$643K	0.35%	96
2013 Q2	$1.68M	Buy	+11,080	New	+$1.57M	0.3%	110

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Azimuth Capital Management's CLB Position: Q3 2015 in Review

Azimuth Capital Management sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 7,380 shares — an estimated $842K sold.

Azimuth Capital Management first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $3.13M in Q1 2014. 351 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

Azimuth Capital Management reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
Azimuth Capital Management sold 7,380 Core Laboratories shares in Q3 2015, an estimated $842K.
Azimuth Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
Azimuth Capital Management's Core Laboratories position peaked at $3.13M in Q1 2014.
351 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Azimuth Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.